Search Results 261-270 of 2559 for 搜索引擎入口咨询邮箱:lgooxc@hotmail.com
Have 2X the impact! ... Make a gift that can go twice as far to advance healthcare research. Give Today.
The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...
Crizotinib and methotrexate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy work in ...
A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor ...
Zhao, Kristin D. Ph.D., M.S. · zhao.kristin@mayo.edu; Associate Professor of Physical Medicine and Rehabilitation; Assistant Professor of Biomedical ...
Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...
Research in the Sarkaria Translational Neuro-Oncology Lab at Mayo Clinic focuses on ADC biology, MDM2 inhibitors, DNA damage response inhibitors and ...
View past members of Mayo Clinic's Bone Injury and Repair Lab led by Abhishek Chandra, Ph.D., M.S..
About this study. The purpose of this study is to collect data on the post-transplant clinical outcomes of donor livers preserved and assessed on OCS Liver ...
All patients who complete the 52-week double-blind treatment period on IP may be eligible to continue into an open label extension (OLE) period. The OLE period ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.